The latest news & events
Keep up to date with company updates, industry news, investor
press releases and event information.
Kneat Announces Record SaaS Revenue in Q1 2022
LIMERICK, Ireland, May 12, 2022 /CNW/ – kneat.com, inc. (TSX: KSI) (“Kneat” or “the Company”), a leader in digitizing and automating validation processes, today announced financial results for the three-month period ended March 31, 2022. All dollar amounts are presented in Canadian dollars unless
Read More
Kneat Announces Release Date for First Quarter Financial Results
LIMERICK, Ireland, May 9, 2022 /CNW/ – kneat.com, inc. (TSX: KSI) (“Kneat” or the “Company”), a leader in digitizing and automating validation processes, announced today that the Company will release its financial results for the quarter ended March 31, 2022, after TSX market close on May 11th,
Read More
Kneat to Exhibit at ISPE Singapore Conference & Exhibition 2022
ISPE Singapore Conference & Exhibition 2022 ISPE Singapore Conference & Exhibition 2022 takes place in Suntec and Online from the…
Read More
Kneat to Exhibit at European QA Congress 2022
European QA Congress 2022 The European QA Congress 2022 takes place virtually on the 11th and 12th of May. Organised…
Read More
Kneat to Attend Pharma Talk EU
Pharma Talk EU Pharma Talk EU takes place in Berlin from 28th-29th June 2022. PharmaTalk is a leading annual meeting…
Read More
Kneat to Exhibit at Bio Talk USA
Bio Talk USA Bio Talk USA takes place in Boston from 8th-9th June 2022. BioTalk is a leading annual meeting…
Read More
Kneat Announces OTCQX Listing and DTC Eligibility
LIMERICK, Ireland, March 31, 2022/CNW/ – kneat.com, inc. (TSX: KSI) (OTCQX: FBAYF) (“ Kneat ” or the “ Company ”) a leader in digitizing and automating validation processes, announced today that its common shares (the “ Shares ”) will commence trading on the OTCQX® Best Market today, under the
Read More
European National Health Service Selects Kneat’s eValidation Platform
LIMERICK, Ireland, March 18, 2022 /CNW/ – kneat.com, inc. (TSX: KSI) (“Kneat” or “the Company”) , a leader in digitizing and automating validation and quality processes, is pleased to announce it has signed a Master Services Agreement with a European national health service. This country’s
Read More
Top Ten Biopharmaceutical Company Selects Kneat as its Enterprise Platform
Kneat Now Counts Eight of the Top Ten Global Pharmaceutical Companies as Customers LIMERICK, Ireland, March 17, 2022 /CNW/ – kneat.com, inc. (TSX: KSI) (“Kneat” or “the Company”) , a leader in digitizing and automating validation and quality processes, is pleased to announce it has signed a
Read More
Leading Canadian Generics Pharmaceutical Manufacturer Selects Kneat’s SaaS E-Validation Platform
LIMERICK, Ireland, March 10, 2022 /CNW/ – kneat.com, inc. (TSX: KSI) (“Kneat” or “the Company”) , a leader in digitizing and automating validation and quality processes, is pleased to announce it has signed a three-year Master Services Agreement with a Canadian-headquartered generics pharmaceutical
Read More
Kneat to Exhibit at The ISPE Boston Product Show 2022
The ISPE Boston Product Show 2022 The ISPE Boston Product Show takes place at the Gillette Stadium in Boston on…
Read More
Kneat to Feature at KENX Biopharmaceutical University
KENX Biopharmaceutical University KENX Biopharmaceutical University takes place in San Diego from 6th-8th June 2022. More than ever before, the…
Read MoreContact
Talk to us
Find out how Kneat can make your validation easier, faster, and smarter.
Start your paperless validation revolution by speaking to our experts.